Dendris SAS is a biotechnology start-up created to exploit recent developments in nanotechnology oriented to life sciences.

Dendris develop an affordable and easy-to-use multiplex diagnosis, for syndrome-based diseases and biomarkers validation. The kit is intended for hospitals and medical analysis laboratories with a user-friendly in vitro diagnosis (IVD) device. In a single test, it provides a rapid and accurate diagnosis, and thus improving and accelerating the medical decision-making. The IVD solution shall lead to a new standard, which could reduce public health costs. Rapid diagnosis delay will establish a faster curative action, and determine the best treatment to prescribe in the context of personalized medicine.

Lower pharmacy expenses


Shorten hospitalisation stays

Improve clinical outcomes